Dedicated to the Science of Impact
When it comes to a diagnosis, DiaCarta understands the impact time and sensitivity can have on testing and treatment outcomes. That’s why we’re dedicated to providing faster, more sensitive solutions for genetic testing and molecular diagnostics. From discovery to commercialization and manufacturing capabilities, DiaCarta is perfecting the science of impact.
DiaCarta Proprietary Technologies and Products
<0.1% sensitivity on difficult or diminished samples
Rapid Results for Faster Diagnosis
First-time results on any sample size in less than two hours
The first and only platform-agnostic technology
GMP-compliant facility with CLIA and CAP certification pending